Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial

Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial

Background The optimal duration of dual antiplatelet therapy after coronary drug‐eluting stent placement in adults with stable coronary artery disease (SCAD) versus acute coronary syndromes (ACS) remains uncertain. Methods and Results This was a prespecified subgroup analysis of the GLOBAL LEADERS t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pascal Vranckx, Marco Valgimigli, Ayodele Odutayo, Patrick W. Serruys, Christian Hamm, Philippe Gabriel Steg, Dik Heg, Eugene P. Mc Fadden, Yoshinobu Onuma, Edouard Benit, Luc Janssens, Roberto Diletti, Maurizio Ferrario, Kurt Huber, Lorenz Räber, Stephan Windecker, Peter Jüni
Format: article
Langue:EN
Publié: Wiley 2021
Sujets:
acute coronary syndrome
all‐comers
antiplatelet therapy
coronary
intervention
stable coronary artery disease
Diseases of the circulatory (Cardiovascular) system
RC666-701
Accès en ligne:https://doaj.org/article/3f8d273488474e0287631cc521cf8542
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/3f8d273488474e0287631cc521cf8542

Documents similaires